Mizuho Medy Co Ltd operates within the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Mizuho Medy Co Ltd with three other
pharmaceutical manufacturers in Asia:
Kainos Laboratories, Inc.
sales of 4.70 billion Japanese Yen [US$41.86 million]
of which 52%
was immunological business),
BioSino Bio-technology and Science Inc
(295.13 million Chinese Renmimbi [US$43.01 million]
based in China
(302.89 million Chinese Renmimbi [US$44.14 million]